Comment on Product developed by Oklahoma cardiologist green-lit for use in COVID-19 treatment

Product developed by Oklahoma cardiologist green-lit for use in COVID-19 treatment

By Dale DenwaltStaff writer ddenwalt@oklahoman.comThe Food and Drug Administration gave remarkably quick, temporary approval to a cardiac monitoring device that helps doctors monitor patients who take a controversial COVID-19 treatment.The device, created by Oklahoma City-founded AliveCor and cardiologist David Albert, M.D., is a personal electrocardiogram that can monitor what's known as QT prolongation.QT prolongation can cause a person's heart to have a potentially deadly arrhythmia, and can develop after taking the drugs hydroxychloroquine and azithromycin.The drugs are being used by doctors to treat some patients with COVID-19, and it's been touted by President Donald Trump as a possible treatment despite the current lack of vigorous research into its off-label use.Read more on NewsOK.com

 

Comment On This Story

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Living News